GlassScriptPhysician profile
Barbara Aldana Blanco
NPI 1669834966
$35,971.76
in general payments reported to CMS, 2019-2025
11 companies · $2,484 in 2025
The $2,484 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23K · 2023: $11K · 2024: $303 · 2025: $2,484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $1,502 · Travel and Lodging: $1,425 · Gift: $10.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,500.00 |
| Food and Beverage | $1,502.05 |
| Travel and Lodging | $1,425.33 |
| Gift | $10.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,820.68 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $681.26 | 2022-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $127.20 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $119.22 | 2022 | |
| Integra Lifesciences Corporation | $78.71 | 2022 | |
| Medtronic, INC. | $34.34 | 2024 | V-Loc 180 |
| Solventum Corporation | $29.07 | 2024 | Prevena, V.A.C. Veraflo |
| Tela Bio, INC. | $22.48 | 2024 | Ovitex 2s |
| Janssen Biotech, INC. | $21.92 | 2025 | Tremfya |
| Madrigal Pharmaceuticals | $20.16 | 2025 | Rezdiffra |
| Hologic INC | $16.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.